Limb girdle muscular dystrophies: clinical-genetical diagnostic update and prospects for therapy

被引:5
作者
Angelini, Corrado [1 ]
Fanin, Marina [2 ]
机构
[1] San Camillo Hosp, Dept Neurodegenerat Disorders, Neuromuscular Ctr, IRCCS, Venice, Italy
[2] Univ Padua, Dept Neurosci, Padua, Italy
关键词
Limb girdle muscular dystrophy; LGMD; diagnosis; treatment; ONSET POMPE DISEASE; LAMIN A/C MUTATIONS; ALPHA-SARCOGLYCAN; BETA-SARCOGLYCAN; MUSCLE PATHOLOGY; MIYOSHI MYOPATHY; PHENOTYPIC VARIABILITY; ADENOASSOCIATED VIRUS; SEVERE CARDIOMYOPATHY; POTENTIAL BIOMARKERS;
D O I
10.1080/21678707.2017.1367283
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Introduction: Limb Girdle Muscular Dystrophies (LGMD) are a clinically heterogeneous group of disorders presenting with a spectrum of disease severity ranging from severe childhood onset muscular dystrophy to adult-onset dystrophy. LGMDs include both dominant and recessive forms. Areas covered: The clinical phenotypes and diagnostic features of LGMD and specific features for each disease have been presented. An updated list of molecularly defined LGMD is provided. The instrumental, muscle imaging, and laboratory exams commonly used to assess final diagnosis are described, as well as recent genetic techniques and new diagnostic procedures, i.e. next generation sequencing, whole exome sequencing, RNA sequencing as compared to other techniques (e.g. protein analysis). The clinical management of patients and their main clinical respiratory and cardiac complications is covered. We also focus on current available future drugs or gene therapy and management by rehabilitation. Expert opinion: Many LGMD cases, who in the past remained for long time without a molecular diagnosis, nowadays can be investigated by next generation sequencing. Gene mutation analysis is always required to obtain a molecular diagnosis, and is fundamental to select patients for future pharmacological trials and gene therapies.
引用
收藏
页码:769 / 784
页数:16
相关论文
共 227 条
[1]   MicroRNA signatures predict dysregulated vitamin D receptor and calcium pathways status in limb girdle muscle dystrophies (LGMD) 2A/2B [J].
Aguennouz, M. ;
Lo Giudice, C. ;
Licata, N. ;
Rodolico, C. ;
Musumeci, O. ;
Fanin, M. ;
Migliorato, A. ;
Ragusa, M. ;
Macaione, V. ;
Di Giorgio, R. M. ;
Angelini, C. ;
Toscano, A. .
CELL BIOCHEMISTRY AND FUNCTION, 2016, 34 (06) :414-422
[2]   GENETIC-HETEROGENEITY OF AUTOSOMAL RECESSIVE LIMB-GIRDLE MUSCULAR-DYSTROPHY IN A GENETIC ISOLATE (AMISH) AND EVIDENCE FOR A NEW LOCUS [J].
ALLAMAND, V ;
BROUX, O ;
BOURG, N ;
RICHARD, I ;
TISCHFIELD, JA ;
HODES, ME ;
CONNEALLY, PM ;
FARDEAU, M ;
JACKSON, CE ;
BECKMANN, JS .
HUMAN MOLECULAR GENETICS, 1995, 4 (03) :459-463
[3]   Secondary reduction in calpain 3 expression in patients with limb girdle muscular dystrophy type 2B and Miyoshi myopathy (primary dysferlinopathies) [J].
Anderson, LVB ;
Harrison, RM ;
Pogue, R ;
Vafiadaki, E ;
Pollitt, C ;
Davison, K ;
Moss, JA ;
Keers, S ;
Pyle, A ;
Shaw, PJ ;
Mahjneh, I ;
Argov, Z ;
Greenberg, CR ;
Wrogemann, K ;
Bertorini, T ;
Goebel, HH ;
Beckmann, JS ;
Bashir, R ;
Bushby, KMD .
NEUROMUSCULAR DISORDERS, 2000, 10 (08) :553-559
[4]  
Angelini C, 1998, MUSCLE NERVE, V21, P769, DOI 10.1002/(SICI)1097-4598(199806)21:6<769::AID-MUS9>3.0.CO
[5]  
2-5
[6]   The clinical spectrum of sarcoglycanopathies [J].
Angelini, C ;
Fanin, M ;
Freda, MP ;
Duggan, DJ ;
Siciliano, G ;
Hoffman, EP .
NEUROLOGY, 1999, 52 (01) :176-179
[7]  
Angelini C, 2011, Acta Myol, V30, P127
[8]   The clinical course of calpainopathy (LGMD2A) and dysferlinopathy (LGMD2B) [J].
Angelini, C. ;
Nardetto, L. ;
Borsato, C. ;
Padoan, R. ;
Fanin, M. ;
Nascimbeni, A. C. ;
Tasca, E. .
NEUROLOGICAL RESEARCH, 2010, 32 (01) :41-46
[9]   DIAGNOSTIC OVERVIEW OF BLOOD-BASED DYSFERLIN PROTEIN ASSAY FOR DYSFERLINOPATHIES [J].
Ankala, Arunkanth ;
Nallamilli, Babi R. ;
Rufibach, Laura E. ;
Hwang, Esther ;
Hegde, Madhuri R. .
MUSCLE & NERVE, 2014, 50 (03) :333-339
[10]   THE FREQUENCY OF PATIENTS WITH DYSTROPHIN ABNORMALITIES IN A LIMB-GIRDLE PATIENT POPULATION [J].
ARIKAWA, E ;
HOFFMAN, EP ;
KAIDO, M ;
NONAKA, I ;
SUGITA, H ;
ARAHATA, K .
NEUROLOGY, 1991, 41 (09) :1491-1496